FDA Clears SQI Diagnostics' Array-Based RA Test for Sale in US

The clearance comes nearly a year after Health Canada granted SQI a license to sell its rheumatoid arthritis test in Canada. According to a company official, the ability to sell to the US not only gives the firm access to a larger market, but "more credibility" globally.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories